Review





Similar Products

99
ATCC ramos b cell lysate ramos ra 1 b cells
Ramos B Cell Lysate Ramos Ra 1 B Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/Ramos/us12656342-490-5-13
Average 99 stars, based on 1 article reviews
ramos b cell lysate ramos ra 1 b cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

93
MedChemExpress cell lysates
Cell Lysates, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/SOD2+Antibody/pm42374427-118-0-19
Average 93 stars, based on 1 article reviews
cell lysates - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

98
Cytiva Europe cell lysates
Cell Lysates, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/HisTrap+FF/us12655405-233-0-16
Average 98 stars, based on 1 article reviews
cell lysates - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

99
Thermo Fisher cell lysates
Cell Lysates, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/Triton+X-100/pm42259249-354-2-35
Average 99 stars, based on 1 article reviews
cell lysates - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

95
Cytiva Europe escc cell lysates
Escc Cell Lysates, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/Sepharose+6B/pm42259163-110-11-28
Average 95 stars, based on 1 article reviews
escc cell lysates - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

86
Servicebio Inc ripa cell lysate
Ripa Cell Lysate, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/lysate+ripa/pmc12860705-568-16-20
Average 86 stars, based on 1 article reviews
ripa cell lysate - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

99
Qiagen cell lysates
a , Immunofluorescence staining of dsDNA (red) and Tom20 (green) in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Scale bar 20µM. Cytosolic dsDNA coverage was determined as a percent (%) of total area. Unpaired Student’s t-test was performed. b-c , Fractionation of 4T1 control (Ctrl sg or sgNTC) or Cpt1a -KO (Cpt1a sg or sgCpt1a) cells was performed to collect the cytosolic fraction. b , Immunoblot to demonstration fractionation. Markers to denote mitochondrial (Mito., CPT1A and VDAC) and cytosolic (Cyto., cGAS and VINCULIN) fractions are shown. <t>Whole</t> <t>cell</t> lysates (WCL) serve as an input control. c , Relative levels of mitochondrial DNA (mtDNA) regions (Dloop1, Dloop2, mt-16S, mt-Nd4) (left) or nuclear DNA (nDNA, Tert) (right) in the cytosolic fraction was determined using RT-PCR. Unpaired Student’s t-tests were performed. d-e , Control (sgNTC) or Cpt1a -KO (sgCpt1a) 4T1 cells were treated with vehicle (VEH) or dideoxycytidine (ddC) to deplete mtDNA. n=3 per group. d , Relative levels of mtDNA regions (left) or nDNA (right) in the cytosolic fraction was determined using RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0181 (Dloop1), p=0.0109 (mt-16S), p=0.0312 (mt-Nd4), p=0.886 (Tert). e , Relative expression of Ifi44, Irf7, Lcn2 , and Slpi was determined by RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0104 (Ifi44), p=0.00637 (Irf7), p=5.45×10 -4 (Lcn2), p=0.00357 (Slpi). f , Schematic model of mtDNA release from the mitochondrial permeability transition pore (mPTP). CypD acts as regulatory subunit of the mPTP, located within the inner mitochondrial space. VDAC acts as a channel on the outer mitochondrial membrane (OMM). Palmitoylation of CypD at C202 (C203 in humans) prevents CypD from interacting with the mPTP to keep the pore in a closed state. g , Immunoblot of S-palmitoylated (S-pal) CypD in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Input shows total CPT1A and CypD levels. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001. ns, not significant.
Cell Lysates, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/QIAamp+DNA+Mini+Kit/bio_rxiv__64898__2026__05__01__722261-209-9-22
Average 99 stars, based on 1 article reviews
cell lysates - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

95
New England Biolabs lysate
a , Immunofluorescence staining of dsDNA (red) and Tom20 (green) in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Scale bar 20µM. Cytosolic dsDNA coverage was determined as a percent (%) of total area. Unpaired Student’s t-test was performed. b-c , Fractionation of 4T1 control (Ctrl sg or sgNTC) or Cpt1a -KO (Cpt1a sg or sgCpt1a) cells was performed to collect the cytosolic fraction. b , Immunoblot to demonstration fractionation. Markers to denote mitochondrial (Mito., CPT1A and VDAC) and cytosolic (Cyto., cGAS and VINCULIN) fractions are shown. <t>Whole</t> <t>cell</t> lysates (WCL) serve as an input control. c , Relative levels of mitochondrial DNA (mtDNA) regions (Dloop1, Dloop2, mt-16S, mt-Nd4) (left) or nuclear DNA (nDNA, Tert) (right) in the cytosolic fraction was determined using RT-PCR. Unpaired Student’s t-tests were performed. d-e , Control (sgNTC) or Cpt1a -KO (sgCpt1a) 4T1 cells were treated with vehicle (VEH) or dideoxycytidine (ddC) to deplete mtDNA. n=3 per group. d , Relative levels of mtDNA regions (left) or nDNA (right) in the cytosolic fraction was determined using RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0181 (Dloop1), p=0.0109 (mt-16S), p=0.0312 (mt-Nd4), p=0.886 (Tert). e , Relative expression of Ifi44, Irf7, Lcn2 , and Slpi was determined by RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0104 (Ifi44), p=0.00637 (Irf7), p=5.45×10 -4 (Lcn2), p=0.00357 (Slpi). f , Schematic model of mtDNA release from the mitochondrial permeability transition pore (mPTP). CypD acts as regulatory subunit of the mPTP, located within the inner mitochondrial space. VDAC acts as a channel on the outer mitochondrial membrane (OMM). Palmitoylation of CypD at C202 (C203 in humans) prevents CypD from interacting with the mPTP to keep the pore in a closed state. g , Immunoblot of S-palmitoylated (S-pal) CypD in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Input shows total CPT1A and CypD levels. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001. ns, not significant.
Lysate, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lysates/NEBExpress+Cell-Free+E%2E+coli+Protein+S/us12606857-648-12-13
Average 95 stars, based on 1 article reviews
lysate - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

Image Search Results


a , Immunofluorescence staining of dsDNA (red) and Tom20 (green) in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Scale bar 20µM. Cytosolic dsDNA coverage was determined as a percent (%) of total area. Unpaired Student’s t-test was performed. b-c , Fractionation of 4T1 control (Ctrl sg or sgNTC) or Cpt1a -KO (Cpt1a sg or sgCpt1a) cells was performed to collect the cytosolic fraction. b , Immunoblot to demonstration fractionation. Markers to denote mitochondrial (Mito., CPT1A and VDAC) and cytosolic (Cyto., cGAS and VINCULIN) fractions are shown. Whole cell lysates (WCL) serve as an input control. c , Relative levels of mitochondrial DNA (mtDNA) regions (Dloop1, Dloop2, mt-16S, mt-Nd4) (left) or nuclear DNA (nDNA, Tert) (right) in the cytosolic fraction was determined using RT-PCR. Unpaired Student’s t-tests were performed. d-e , Control (sgNTC) or Cpt1a -KO (sgCpt1a) 4T1 cells were treated with vehicle (VEH) or dideoxycytidine (ddC) to deplete mtDNA. n=3 per group. d , Relative levels of mtDNA regions (left) or nDNA (right) in the cytosolic fraction was determined using RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0181 (Dloop1), p=0.0109 (mt-16S), p=0.0312 (mt-Nd4), p=0.886 (Tert). e , Relative expression of Ifi44, Irf7, Lcn2 , and Slpi was determined by RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0104 (Ifi44), p=0.00637 (Irf7), p=5.45×10 -4 (Lcn2), p=0.00357 (Slpi). f , Schematic model of mtDNA release from the mitochondrial permeability transition pore (mPTP). CypD acts as regulatory subunit of the mPTP, located within the inner mitochondrial space. VDAC acts as a channel on the outer mitochondrial membrane (OMM). Palmitoylation of CypD at C202 (C203 in humans) prevents CypD from interacting with the mPTP to keep the pore in a closed state. g , Immunoblot of S-palmitoylated (S-pal) CypD in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Input shows total CPT1A and CypD levels. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001. ns, not significant.

Journal: bioRxiv

Article Title: CPT1A loss promotes lung metastasis in immune-competent mice via a mechanism of mtDNA release and chronic activation of STING pathway

doi: 10.64898/2026.05.01.722261

Figure Lengend Snippet: a , Immunofluorescence staining of dsDNA (red) and Tom20 (green) in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Scale bar 20µM. Cytosolic dsDNA coverage was determined as a percent (%) of total area. Unpaired Student’s t-test was performed. b-c , Fractionation of 4T1 control (Ctrl sg or sgNTC) or Cpt1a -KO (Cpt1a sg or sgCpt1a) cells was performed to collect the cytosolic fraction. b , Immunoblot to demonstration fractionation. Markers to denote mitochondrial (Mito., CPT1A and VDAC) and cytosolic (Cyto., cGAS and VINCULIN) fractions are shown. Whole cell lysates (WCL) serve as an input control. c , Relative levels of mitochondrial DNA (mtDNA) regions (Dloop1, Dloop2, mt-16S, mt-Nd4) (left) or nuclear DNA (nDNA, Tert) (right) in the cytosolic fraction was determined using RT-PCR. Unpaired Student’s t-tests were performed. d-e , Control (sgNTC) or Cpt1a -KO (sgCpt1a) 4T1 cells were treated with vehicle (VEH) or dideoxycytidine (ddC) to deplete mtDNA. n=3 per group. d , Relative levels of mtDNA regions (left) or nDNA (right) in the cytosolic fraction was determined using RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0181 (Dloop1), p=0.0109 (mt-16S), p=0.0312 (mt-Nd4), p=0.886 (Tert). e , Relative expression of Ifi44, Irf7, Lcn2 , and Slpi was determined by RT-PCR. Two-way ANOVA with Tukey’s post hoc; p=0.0104 (Ifi44), p=0.00637 (Irf7), p=5.45×10 -4 (Lcn2), p=0.00357 (Slpi). f , Schematic model of mtDNA release from the mitochondrial permeability transition pore (mPTP). CypD acts as regulatory subunit of the mPTP, located within the inner mitochondrial space. VDAC acts as a channel on the outer mitochondrial membrane (OMM). Palmitoylation of CypD at C202 (C203 in humans) prevents CypD from interacting with the mPTP to keep the pore in a closed state. g , Immunoblot of S-palmitoylated (S-pal) CypD in control (sgNTC) and Cpt1a -KO (sgCpt1a) 4T1 cells. Input shows total CPT1A and CypD levels. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001. ns, not significant.

Article Snippet: For mitochondrial DNA (mtDNA) quantification, DNA was isolated from whole-cell lysates, cytosolic fractions, or mitochondria-enriched fractions using the QIAamp DNA Mini Kit (Qiagen #51304).

Techniques: Immunofluorescence, Staining, Control, Fractionation, Western Blot, Reverse Transcription Polymerase Chain Reaction, Expressing, Permeability, Membrane